Healthy pregnancy hub

Zolpidem (Sublinox®)

Last Update: 09 Sep 2025

Welcome to our fact sheet on zolpidem during pregnancy and breastfeeding or chestfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (June 2024).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is zolpidem?

Zolpidem is a sedative-hypnotic medication (causes calm and sleep) that has been used to treat insomnia (not being able to fall asleep or stay asleep). It belongs to a group of medications called hypnotic benzodiazepine receptor agonists, or HBRAs (sometimes called z-hypnotics or z-drugs). HBRAs are not benzodiazepines, but they work in a similar way. Some brand names of zolpidem are Ambien®, Edluar®, and Intermezzo®. In Canada, it can be found under the name Sublinox®. 

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Some people who stop taking zolpidem suddenly might experience withdrawal symptoms like fatigue, nausea, vomiting, flushing, light headedness, crying, and nervousness. Your healthcare providers can talk with you about the benefits of treating insomnia, and the risks of untreated insomnia during pregnancy. 

2. What does research say about the risks during pregnancy?

I take zolpidem. Can it make it harder for me to get pregnant?

Studies have not been done to see if taking zolpidem can make it harder to get pregnant. 

Does taking zolpidem increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. It is not known if zolpidem can increase the chance of miscarriage. 

Does taking zolpidem increase the chance of birth defects?

Birth defects can happen in any pregnancy for different reasons. Out of all babies born each year, about 3 out of 100 (3%) will have a birth defect. We look at research studies to try to understand if an exposure, like zolpidem, can increase the chance of birth defects in a pregnancy. Several studies have reported no increased chance of birth defects with the use of zolpidem during pregnancy. 

Does taking zolpidem in pregnancy increase the chance of other pregnancy-related problems?

Several studies have found that using zolpidem during pregnancy does not greatly increase the chance of other pregnancy-related problems, such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth). Other studies have found that people who took zolpidem during pregnancy were slightly more likely to deliver early or have smaller babies compared with people who did not take these medications during pregnancy. These studies did not consider other factors, such as the use of other medications, smoking, alcohol or drug use, or the underlying medical condition that the medication was used to treat. This makes it hard to know if the medication, illnesses being treated, or other factors are the reason for the reported issues. 

Does taking zolpidem in pregnancy affect future behavior or learning for the child? 

It is not known if zolpidem can increase the chance of behavior or learning issues for the child. 

3. Breastfeeding​/ chestfeeding​ while taking zolpidem

Zolpidem passes into human milk in small amounts. One small study and a case report found that 6 persons who took zolpidem during the days after delivery had small amounts of the medication in their milk three hours after taking it. No problems were reported in their babies. If you suspect the baby has any symptoms (being very sleepy, trouble gaining weight, low muscle tone or floppiness, or slow breathing), contact the child’s healthcare provider. Be sure to talk to your healthcare provider about all your breastfeeding or chestfeeding questions. 

4. What about fathers and sperm donors?

If a male takes zolpidem, could it affect fertility or increase the chance of birth defects? 

Studies have not been done to see if zolpidem could affect male’s fertility (ability to get a person pregnant) or increase the chance of birth defects. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Zolpidem (Sublinox®) is a medication prescribed to treat insomnia and help people sleep. It is not a benzodiazepine, but works in a similar way.  
  • We don’t know if zolpidem makes it harder to get pregnant or increases the chance of miscarriage. 
  • Most studies show that zolpidem does not increase the chance of birth defects. 
  • Some studies found a slight increase in preterm birth or low birth weight, while others found no extra risk.
  • Zolpidem passes into human milk in small amounts. One small study didn’t find problems in babies, but it’s important to watch for signs like too much sleepiness or trouble feeding.  
  • Always talk to your healthcare provider before stopping or making changes to your medication during pregnancy and breastfeeding or chestfeeding. 

References

Please click here for references. 

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Sasha Bernatsky
Research Institute of the McGill University Health Centre
Evelyne Rey
CHU Sainte-Justine
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Our interactive tools

Ask your questions and receive help from our personalized AI.

Try it now!

Explore our reading assistance tool.

Test them out today!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University